AlphaYouJI
Congress trade
Sen. James Inhofe (R-OK) bought $15K-$50K of CRISPR Therapeutics AG (CRSP) stock
James Inhofe, U.S. Senator (R-OK), disclosed a purchase of CRISPR Therapeutics AG (CRSP) stock worth $15K-$50K in a STOCK Act filing on Nov 8, 2017.
The trade happened on Oct 19, 2017, 20 days before it was made public.
CRSP has moved +192.2% since the trade date, from $18.97 to $55.43 (Oct 2, 2026 close).
- Traded
- Oct 19, 2017
- Disclosed
- Nov 8, 2017
- Filing delay
- 20 days
- Price since
- +192.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (10)
More CRSP insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.